Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep '25 Sep 27, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
US Revenue	3.26B	3.12B
Other Established Markets Revenue	1.80B	1.71B
Total Established Markets Revenue	5.05B	4.83B
Emerging Markets Revenue	979.00M	980.00M
Revenue (Total)	-	5.81B

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep '25 Sep 27, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Knee Implants Revenue	982.00M	947.00M
Hip Implants Revenue	628.00M	619.00M
Other Reconstruction Revenue	132.00M	131.00M
Trauma & Extremities Revenue	636.00M	608.00M
Total Orthopaedics Revenue	2.38B	2.31B
Sports Medicine Joint Repair Revenue	1.03B	982.00M
Arthroscopic Enabling Technologies Revenue	637.00M	632.00M
ENT (Ear, Nose and Throat) Revenue	218.00M	210.00M
Total Sports Medicine & ENT Revenue	1.89B	1.82B
Advanced Wound Care Revenue	749.00M	735.00M
Advanced Wound Bioactives Revenue	622.00M	581.00M
Advanced Wound Devices Revenue	397.00M	365.00M
Total Advanced Wound Management Revenue	1.77B	1.68B
Revenue (Total)	-	5.81B

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Orthopaedics Segment Profit	265.00M
Sports Medicine & ENT Segment Profit	437.00M
Advanced Wound Management Segment Profit	399.00M
Operating Income (Other)	-444.00M
Operating Income (Total)	657.00M

Updated Sep 27, 2025. Data Source: Fiscal.ai.